NCT06587685View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

November 19, 2024

Study Completion Date

January 15, 2026

Conditions
Atopic Dermatitis
Interventions
DRUG

PG-011Gel

Twice daily for 52 weeks or 44 weeks

DRUG

Vehicle

Vehicle Gel twice daily for 8 weeks

Trial Locations (1)

Unknown

RECRUITING

The First Hospital of China Medical University, Shenyang

Sponsors
All Listed Sponsors
lead

Prime Gene Therapeutics Co., Ltd.

INDUSTRY

NCT06587685 - A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis | Biotech Hunter | Biotech Hunter